295 related articles for article (PubMed ID: 32536911)
1. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway.
Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH
Front Immunol; 2020; 11():848. PubMed ID: 32536911
[TBL] [Abstract][Full Text] [Related]
2. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
Pang Y; Tan Y; Li Y; Zhang J; Guo Y; Guo Z; Zhang C; Yu F; Zhao MH
Kidney Int; 2016 Dec; 90(6):1357-1367. PubMed ID: 27745701
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q Autoantibodies: Standard Quantification and Innovative ELISA.
Csorba K; Schirmbeck L; Dubler D; Trendelenburg M
Methods Mol Biol; 2021; 2227():107-114. PubMed ID: 33847935
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
5. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
6. Biochemical analysis of the epitope specificities of anti-C1q autoantibodies accompanying human lupus nephritis reveals them as a dynamic population in the course of the disease.
Stoyanova V; Tchorbadjieva M; Deliyska B; Vasilev V; Tsacheva I
Immunol Lett; 2012; 148(1):69-76. PubMed ID: 22981967
[TBL] [Abstract][Full Text] [Related]
7. Functional definition of a B cell epitope, KGEQGEPGA, on C1q the Fc-binding subunit of the first component of complement.
Trinder PK; Märker-Hermann E; Loos M; Maeurer MJ
Scand J Immunol; 1999 Dec; 50(6):635-41. PubMed ID: 10607312
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
9. Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.
Kleer JS; Rabatscher PA; Weiss J; Leonardi J; Vogt SB; Kieninger-Gräfitsch A; Chizzolini C; Huynh-Do U; Ribi C; Trendelenburg M
Front Immunol; 2021; 12():761395. PubMed ID: 35087514
[TBL] [Abstract][Full Text] [Related]
10. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
Radanova M; Vasilev V; Deliyska B; Kishore U; Ikonomov V; Ivanova D
Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
[TBL] [Abstract][Full Text] [Related]
11. Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
Gatto M; Ghirardello A; Luisetto R; Bassi N; Fedrigo M; Valente M; Valentino S; Del Prete D; Punzi L; Doria A
J Autoimmun; 2016 Nov; 74():208-216. PubMed ID: 27405845
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1q autoantibodies in murine lupus nephritis.
Trouw LA; Seelen MA; Visseren R; Duijs JM; Benediktsson H; de Heer E; Roos A; van Kooten C; Daha MR
Clin Exp Immunol; 2004 Jan; 135(1):41-8. PubMed ID: 14678263
[TBL] [Abstract][Full Text] [Related]
13. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
Jiang HX; Siegel JN; Gewurz H
J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
[TBL] [Abstract][Full Text] [Related]
14. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
Deliyska B; Tsacheva I; Radanova M; Stoianova V; Tchorbadjieva M; Dobreva N
Med Pregl; 2007; 60 Suppl 2():25-7. PubMed ID: 18928152
[TBL] [Abstract][Full Text] [Related]
15. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M
Front Immunol; 2019; 10():2619. PubMed ID: 31787984
[TBL] [Abstract][Full Text] [Related]
16. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.
O'Flynn J; Flierman R; van der Pol P; Rops A; Satchell SC; Mathieson PW; van Kooten C; van der Vlag J; Berden JH; Daha MR
Mol Immunol; 2011 Oct; 49(1-2):75-83. PubMed ID: 21855148
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
18. Binding of the human complement subcomponent C1q to hybrid mouse monoclonal antibodies.
Koolwijk P; Boot JH; Griep R; Bast BJ
Mol Immunol; 1991 Jun; 28(6):567-76. PubMed ID: 1861677
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
